FDAFDA · Food and drugs·Recall number D-1292-2022
Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), 3 mL prefilled pens (NDC 49502-394-71), packaged in cartons of 5 prefilled pens (NDC 49502-394-75), Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 15317, Manufactured for: Mylan Specialty L.P., Morgantown, WV
Published August 3, 2022 · Recall initiated: July 5, 2022
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Missing label: Label missing from some prefilled pens.
What to do
Voluntary: Firm initiated · Press Release
Recall details
- Manufacturer
- Mylan Pharmaceuticals Inc
- Distributor
- Product was distributed nationwide within the United States
- Lot
- Lot #: BF21002895, Exp. Date Aug 2023
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.